Security key
55279B202
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)
CUSIP: 55279B202
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock, $0.00000002 par value
- Shares outstanding
- 29,545,622
- Total 13F shares
- 6,477,857
- Share change
- +379,052
- Total reported value
- $9,326,000
- Price per share
- $1.44
- Number of holders
- 33
- Value change
- +$440,611
- Number of buys
- 8
- Number of sells
- 17
Report period
Q4 2016
Institutions
33
Top holders
10
MEIP full security history
Newer quarter: Q1 2017
Previous quarter: Q3 2016
Lite Strategy, Inc. SEC filings
Lite Strategy, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55279B202
Recent filing periods:
Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4%
|
1,175,059
|
$2,068,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
1,097,959
|
$1,932,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.5%
|
448,639
|
$790,000 | — | 30 Sep 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
427,500
|
$752,000 | — | 30 Sep 2016 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.4%
|
404,975
|
$713,000 | — | 30 Sep 2016 | |
| Ancora Advisors LLC |
13F
|
Company |
1.3%
|
375,000
|
$660,000 | — | 30 Sep 2016 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
1%
|
300,000
|
$528,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.88%
|
261,447
|
$460,000 | — | 30 Sep 2016 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.86%
|
253,757
|
$447,000 | — | 30 Sep 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.43%
|
128,410
|
$226,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
127,975
|
$225,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.24%
|
71,110
|
$125,000 | — | 30 Sep 2016 | |
| KEYBANK NATIONAL ASSOCIATION/OH |
13F
|
Company |
0.2%
|
57,642
|
$101,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
55,477
|
$98,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
51,429
|
$91,000 | — | 30 Sep 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.14%
|
40,382
|
$71,000 | — | 30 Sep 2016 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.1%
|
30,681
|
$54,000 | — | 30 Sep 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
27,057
|
$48,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
23,445
|
$41,000 | — | 30 Sep 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.08%
|
22,985
|
$40,000 | — | 30 Sep 2016 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.07%
|
20,000
|
$34,000 | — | 30 Sep 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
19,793
|
$35,000 | — | 30 Sep 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.06%
|
16,621
|
$29,000 | — | 30 Sep 2016 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.05%
|
15,600
|
$27,000 | — | 30 Sep 2016 | |
| Gilman Hill Asset Management, LLC |
13F
|
Company |
0.05%
|
13,316
|
$23,000 | — | 30 Sep 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.04%
|
12,407
|
$22,000 | — | 30 Sep 2016 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
9,495
|
$17,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.03%
|
8,459
|
$15,000 | — | 30 Sep 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
8,200
|
$14,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.02%
|
5,118
|
$9,000 | — | 30 Sep 2016 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,305
|
$8,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,024
|
$4,000 | — | 30 Sep 2016 | |
| IFP Advisors, Inc |
13F
|
Company |
0.01%
|
2,000
|
$4,000 | — | 30 Sep 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
1,800
|
$3,000 | — | 30 Sep 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.01%
|
1,500
|
$3,000 | — | 30 Sep 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
1,142
|
$2,000 | — | 30 Sep 2016 | |
| MONETARY MANAGEMENT GROUP INC |
13F
|
Company |
0%
|
300
|
$1,000 | — | 30 Sep 2016 |
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2016
As of 31 Dec 2016,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,477,857 shares.
The largest 10 holders included
Anson Funds Management LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, INTERWEST VENTURE MANAGEMENT CO, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, Connor, Clark & Lunn Investment Management Ltd., Ancora Advisors, LLC, FMR LLC, and WASATCH ADVISORS INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
36
Q4 2016 holders
33
Holder diff
-3
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.